Original language | English |
---|---|
Pages (from-to) | e75-e76 |
Journal | European Urology |
Volume | 70 |
Issue number | 3 |
DOIs | |
State | Published - Sep 1 2016 |
Reply to Francesco Piva, Matteo Santoni, Marina Scarpelli, et al's Letter to the Editor re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912–4
Tim N. Beck, Erica A. Golemis, Daniel M. Geynisman
Research output: Contribution to journal › Letter › peer-review